369 related articles for article (PubMed ID: 28812919)
21. Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma.
Augsburger JJ; Gamel JW; Lauritzen K; Brady LW
Am J Ophthalmol; 1990 May; 109(5):585-92. PubMed ID: 2333923
[TBL] [Abstract][Full Text] [Related]
22. Management of radiation-induced severe anophthalmic socket contracture in patients with uveal melanoma.
Nasser QJ; Gombos DS; Williams MD; Guadagnolo BA; Morrison WH; Garden AS; Beadle BM; Canseco E; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2012; 28(3):208-12. PubMed ID: 22581085
[TBL] [Abstract][Full Text] [Related]
23. Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit.
Sánchez-Tabernero S; García-Alvarez C; Muñoz-Moreno MF; Diezhandino P; Alonso-Martínez P; de Frutos-Baraja JM; López-Lara F; Saornil MA
Am J Ophthalmol; 2017 Aug; 180():39-45. PubMed ID: 28572063
[TBL] [Abstract][Full Text] [Related]
24. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial.
Char DH; Quivey JM; Castro JR; Kroll S; Phillips T
Ophthalmology; 1993 Oct; 100(10):1547-54. PubMed ID: 8414414
[TBL] [Abstract][Full Text] [Related]
25. High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome.
Fili M; Lundell G; Lundell M; Seregard S
Br J Ophthalmol; 2014 Oct; 98(10):1349-54. PubMed ID: 24825846
[TBL] [Abstract][Full Text] [Related]
26. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: evaluation of 175 patients treated with 150 Gy from 1981-1989.
Pötter R; Janssen K; Prott FJ; Widder J; Haverkamp U; Busse H; Müller RP
Front Radiat Ther Oncol; 1997; 30():143-9. PubMed ID: 9205894
[No Abstract] [Full Text] [Related]
27. Ruthenium-106 plaque brachytherapy for uveal melanoma.
Tarmann L; Wackernagel W; Avian A; Mayer C; Schneider M; Winkler P; Langmann G
Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
[TBL] [Abstract][Full Text] [Related]
28. 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
McCannel TA; Kamrava M; Demanes J; Lamb J; Bartlett JD; Almanzor R; Chun M; McCannel CA
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2461-2467. PubMed ID: 27638702
[TBL] [Abstract][Full Text] [Related]
29. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.
Barker CA; Francis JH; Cohen GN; Marr BP; Wolden SL; McCormick B; Abramson DH
Brachytherapy; 2014; 13(6):584-90. PubMed ID: 24880583
[TBL] [Abstract][Full Text] [Related]
30. [Iodine-125 brachytherapy and trans-scleral tumor resection in large uveal melanomas].
Bechrakis NE; Bornfeld N; Zöller I; Foerster MH
Ophthalmologe; 2001 Aug; 98(8):736-42. PubMed ID: 11552413
[TBL] [Abstract][Full Text] [Related]
31. Episcleral plaque radiotherapy for uveal melanoma.
Giblin ME; Shields JA; Augsburger JJ; Brady LW
Aust N Z J Ophthalmol; 1989 May; 17(2):153-6. PubMed ID: 2667581
[TBL] [Abstract][Full Text] [Related]
32. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
[TBL] [Abstract][Full Text] [Related]
33. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
[TBL] [Abstract][Full Text] [Related]
34. Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy.
Char DH; Kroll S; Quivey JM; Castro J
Br J Ophthalmol; 1996 Feb; 80(2):117-24. PubMed ID: 8814740
[TBL] [Abstract][Full Text] [Related]
35. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings.
Shields CL; Shields JA; Karlsson U; Menduke H; Brady LW
Ophthalmology; 1990 Dec; 97(12):1665-70. PubMed ID: 2087297
[TBL] [Abstract][Full Text] [Related]
36. Analysis of melanoma cell type in uveal melanoma following treatment failure.
Char DH; Miller T; Crawford JB
Am J Ophthalmol; 2004 Oct; 138(4):543-6. PubMed ID: 15488778
[TBL] [Abstract][Full Text] [Related]
37. Iodine-I25 episcleral plaque therapy in uveal melanoma.
Sia S; Harper C; McAllister I; Perry A
Clin Exp Ophthalmol; 2000 Dec; 28(6):409-13. PubMed ID: 11202462
[TBL] [Abstract][Full Text] [Related]
38. Socket outcomes following enucleation for uveal melanoma: post enucleation socket syndrome can be challenging.
Quigley C; Elshelmani H; Fajin G; Byrne AM; McCloskey C; O'Neill V; Horgan N
Eye (Lond); 2024 Jan; 38(1):192-197. PubMed ID: 37407695
[TBL] [Abstract][Full Text] [Related]
39. [Method of implant insertion in anophthalmic socket].
Brovkina AF; Stoiukhina AS
Vestn Oftalmol; 2011; 127(1):48-50. PubMed ID: 21539107
[TBL] [Abstract][Full Text] [Related]
40. A choice of radionuclide: Comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma.
Takiar V; Voong KR; Gombos DS; Mourtada F; Rechner LA; Lawyer AA; Morrison WH; Garden AS; Beadle BM
Pract Radiat Oncol; 2015; 5(3):e169-e176. PubMed ID: 25423888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]